Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Laromestracel in Alzheimer Disease: TCTR20260320005 Clinical Landscape Report 2026
15 October 2026
TCTR20260320005 clinical landscape for Alzheimer Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
XNW-27011 in Pancreatic adenocarcinoma: NCT07488676 Clinical Landscape Report 2026
15 October 2026
NCT07488676 clinical landscape for Pancreatic adenocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Meta10-GPC3 in Unresectable Hepatocellular Carcinoma: NCT07487402 Clinical Landscape Report 2026
15 October 2026
NCT07487402 clinical landscape for Unresectable Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white…
9 min read
Super CAR-T(FineImmune Biotechnology) in GPC3 Positive Hepatocellular Carcinoma: NCT07493044 Clinical Landscape Report 2026
15 October 2026
NCT07493044 clinical landscape for GPC3 Positive Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development whit…
9 min read
LYNC-101 in Colitis, Ulcerative: NCT07505030 Clinical Landscape Report 2026
15 October 2026
NCT07505030 clinical landscape for Colitis, Ulcerative: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
QLH2405 in Alzheimer Disease: NCT07489599 Clinical Landscape Report 2026
15 October 2026
NCT07489599 clinical landscape for Alzheimer Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
CKDB-001 in Alzheimer Disease: NCT07496021 Clinical Landscape Report 2026
15 October 2026
NCT07496021 clinical landscape for Alzheimer Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
iNeo-Vac-R01 in Hepatocellular Carcinoma: NCT07495215 Clinical Landscape Report 2026
15 October 2026
NCT07495215 clinical landscape for Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
RP-001-Taxane in Colorectal Cancer: NCT07504263 Clinical Landscape Report 2026
15 October 2026
NCT07504263 clinical landscape for Colorectal Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
EB-G3B7-NK in Liver metastases: NCT07500220 Clinical Landscape Report 2026
15 October 2026
NCT07500220 clinical landscape for Liver metastases: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Upadacitinib hemihydrate in Colitis, Ulcerative: NCT07502339 Clinical Landscape Report 2026
15 October 2026
NCT07502339 clinical landscape for Colitis, Ulcerative: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Respiratory Syncytial Virus Vaccine (GSK) in Pulmonary Disease, Chronic Obstructive: NCT07508644 Clinical Landscape Report 2026
15 October 2026
NCT07508644 clinical landscape for Pulmonary Disease, Chronic Obstructive: endpoints, sponsor, phase, geography, readouts, asset context and development whit…